Table 4. Factors associated with colorectal cancer mortality (N = 18,816).
Factors | No. of deaths | 1,000 person- years | Crude HR | P-value |
---|---|---|---|---|
Age category | ||||
< 50 | 0 | 0 | 1 | |
50–59 | 0 | 0 | NA | NA |
60–69 | 0 | 0 | NA | NA |
70–79 | 2 | 0.123 | NA | NA |
≥ 80 | 2 | 0.580 | NA | NA |
Sex | ||||
Female | 2 | 0.105 | 1 | |
Male | 2 | 0.042 | 0.41 (0.06–2.92) | 0.374 |
Current smoker | 0 | 0 | NA | NA |
Family history of CRC | 0 | 0 | NA | NA |
Comorbidities | ||||
Ischemic heart diseases | 2 | 0.135 | 3.65 (0.51–25.9) | 0.196 |
Chronic heart failure | 2 | 0.208 | 6.13 (0.86–43.6) | 0.070 |
Peripheral vascular diseases | 2 | 0.290 | 9.59 (1.35–68.1) | 0.024 |
Cerebral vascular diseases | 1 | 0.147 | 2.99 (0.31–28.7) | 0.344 |
Dementia | 0 | 0 | NA | NA |
COPD | 1 | 0.502 | 11.1 (1.15–106.5) | 0.037 |
Collagen diseases | 0 | 0 | NA | NA |
Peptic ulcer diseases | 3 | 0.094 | 3.39 (0.35–32.6) | 0.291 |
Diabetes mellitus | 3 | 0.109 | 4.66 (0.48–44.8) | 0.183 |
Chronic kidney diseases | 0 | 0 | NA | NA |
Paresthesia | 0 | 0 | NA | NA |
Leukemia | 0 | 0 | NA | NA |
Malignant lymphoma | 0 | 0 | NA | NA |
Liver cirrhosis | 0 | 0 | NA | NA |
AIDS | 0 | 0 | NA | NA |
Indication for colonoscopy | ||||
Positive FIT | 1 | 0.060 | 1.00 (0.10–9.60) | 0.999 |
Initial colonoscopy findings | ||||
Polyp detection | 2 | 0.064 | 1.14 (0.16–8.07) | 0.898 |
10-mm adenoma detection† | 0 | 0 | NA | NA |
20-mm adenoma detection† | 0 | 0 | NA | NA |
Therapeutic colonoscopies | 0 | 0 | NA | NA |
Number of colonoscopies | ||||
1 | 0 | 0 | NA | NA |
2 | 3 | 0.130 | 1 | |
3 | 1 | 0.106 | 1.60 (0.17–15.3) | 0.686 |
4 | 0 | 0 | NA | NA |
5 | 0 | 0 | NA | NA |
6 | 0 | 0 | NA | NA |
7 | 0 | 0 | NA | NA |
†The crude and adjusted hazard ratios of 10-mm and 20-mm adenoma detection were calculated using imputation data.
CRC, colorectal cancer; COPD, chronic pulmonary disease; AIDS, acquired immune deficiency syndrome; FIT, fecal immunochemical test; HR, hazard ratio; NA, not applicable.